Status:
UNKNOWN
The Combination Therapy of Fractional Laser and PRP Compared With Nanofat Grafting and PRP Synergy in Treating Striae Gravidarum.
Lead Sponsor:
First Affiliated Hospital of Jinan University
Collaborating Sponsors:
Science and Technology Program of Guangzhou
Conditions:
Treatments of Striae Gravidarum
Eligibility:
FEMALE
Up to 35 years
Phase:
PHASE3
Brief Summary
Nowadays, multiple treatment modalities have been applied clinically to treat striae gravidarum, such as laser therapy, microdermabrasion, platelet-rich plasma injection(PRP), etc. To some extent, the...
Detailed Description
The investigators will pick out two areas of most severe striae gravidarum on a participant's abdomen. One of the areas will be treated by fractional laser once every three months for 2 times combined...
Eligibility Criteria
Inclusion
- The striae gravidarum was appeared within 3 years
- Age ≤ 35 years old
- Not in lactation
- Not pregnancy within one year
Exclusion
- Skin allergy
- Skin inflammation or wound
- Platelet dysfunction syndrome
- Take anticoagulant drugs
- Acute or chronic infection
- Chronic liver disease
- Photodermatosis
- Active vitiligo, psoriasis, systemic lupus erythematosus
- Other clinical trial
Key Trial Info
Start Date :
April 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2018
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03328871
Start Date
April 1 2017
End Date
November 1 2018
Last Update
May 25 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital of Jinan University
Guangzhou, Guangdong, China, 500011